Drug intelligence / Profile preview

pM-PTH(1-11)

Development stage
Preclinical
Lead developer
Harvard Medical School
Modality
Peptides
Administration
Subcutaneous
01

Overview

pM-PTH(1-11), also known as palmitoyl(p)M-PTH(1-11) or Palm-11-M-PTH(1-11), is a lipidated parathyroid hormone (PTH) peptide fragment analog that acts as a potent agonist of the parathyroid hormone 1 receptor (PTH1R). Developed by researchers at Massachusetts General Hospital and Harvard Medical School, the peptide features a palmitoyl lipid chain appended to the side chain of lysine at position 11. This modification is designed to anchor the ligand to the cell membrane, extending receptor dwell time and prolonging downstream signaling. pM-PTH(1-11) is being preclinically evaluated for the treatment of skeletal dysplasias, specifically achondroplasia, where intermittent subcutaneous administration has been shown to improve growth plate architecture and promote longitudinal bone growth in mouse models.

Other names
K11(R)palm-PTH(1-11)Palm-11-M-PTH(1-11)palmitoyl(p)M-PTH(1-11)
02

Targets

PTH1R (Parathyroid hormone/Parathyroid hormone-related peptide receptor type 1)

Beyond the preview

Go deeper on pM-PTH(1-11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pM-PTH(1-11).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call